Jenburkt Pharmaceuticals and markets pharmaceutical formulations in India and internationally across 13 countries. With over 850+ committed team members across functions pan-India, we promote all our 85 brands across 100,000+ doctors regularly. The company has more than 1,000 stockists and our reach extends to 400,000+ pharmacies across the globe. The organisation caters to large government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Our products are also being exported to 13 countries globally.
Read : Upcoming Buyback 2022
Jenburkt Pharmaceuticals Buyback 2022 Date & Details
| Buyback Open Date | 14 Dec 2022 |
| Buyback Close Date | 13 June 2023 |
| Buyback Price | 702 Rs |
| CMP | 644 Rs |
| Issue Size | 11.60 Crores |
| Security Name | Jenburkt Pharmaceuticals Ltd |
| Face value | 10 |
| Listing At | BSE,NSE |
| Issue Type | Open Market Through Stock Exchange |
| Public Announcement Letter | Download |
Jenburkt Pharmaceuticals Contact Address
Jenburkt Pharmaceuticals Ltd
Nirmala Apartments, 93,
J. P. Road, Andheri (W),
Mumbai 400058,
Phone: +91 22 67603603
Email: [email protected]
Website: https://jenburkt.com/
Jenburkt Pharmaceuticals Buyback Manager
DAM Capital Advisors Limited
Address: One BKC, Tower C, 15th Floor, Unit No. 1511,
Bandra Kurla Complex, Bandra (East),
Mumbai 400 051, Maharashtra, India
Tel: +91 22 4202 2500;
Fax: +91 22-4202 2504;
Contact Person: Rajesh Tekadiwala
Email: [email protected]
Website: www.damcapital.in
SEBI Registration Number: INZ000207137
Validity Period: Permanent
CIN: U99999MH1993PLC071865
Jenburkt Pharmaceuticals Buyback Register
Bigshare Services Private Limited
Address : Office No S6-2, 6th Floor, Pinnacle Business
Park, Next to Ahura Centre, Mahakali
Caves Road, Andheri (East) Mumbai – 400093
Tel : 022 – 62638200
Fax : 022- 62638299
Contact Person : Swapnil Kate
Email ID : [email protected]
Website : www.bigshareonline.com
SEBI
Registration
Number : INR000001385
Validity Period : Permanent
CIN : U99999MH1994PTC076534
